Skip to content

TherapeuticsMD, Inc.: filings

Every TherapeuticsMD, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 60 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-11fiscal Q2 202630870001213900-26-087768
10-Q2026-05-12fiscal Q1 202631630001213900-26-055081
10-K/A2026-04-01fiscal FY 202530600001213900-26-037918
10-K2026-03-30fiscal FY 202530600001213900-26-036515
10-Q2025-11-12fiscal Q3 202529880001213900-25-109381
10-Q2025-08-12fiscal Q2 202529830001213900-25-075003
10-Q2025-05-13fiscal Q1 202530610001213900-25-042697
10-K2025-03-27fiscal FY 202434660001013762-25-003442
10-Q2024-08-12fiscal Q2 202431900001213900-24-067771
10-K2024-03-29fiscal FY 202341780001213900-24-028003
10-Q2023-11-14fiscal Q3 2023391180001193125-23-277143
10-Q2023-08-14fiscal Q2 2023391130001193125-23-211458
10-Q2023-05-15fiscal Q1 202340750001193125-23-145064
10-K2023-04-07fiscal FY 202242830001564590-23-005514
10-Q2022-11-14fiscal Q3 2022491460001564590-22-037666
10-Q2022-08-15fiscal Q2 2022491410001564590-22-029490
10-Q2022-05-16fiscal Q1 202245930001564590-22-020440
10-K2022-03-23fiscal FY 2021461500001564590-22-011525
10-Q2021-11-12fiscal Q3 2021441240001564590-21-056434
10-Q2021-08-04fiscal Q2 2021441200001564590-21-040907
10-Q2021-05-06fiscal Q1 202143890001193125-21-153419
10-K2021-03-04fiscal FY 2020431360001387131-21-003140
10-Q2020-11-09fiscal Q3 2020421160001387131-20-009695
10-Q2020-08-07fiscal Q2 2020421140001387131-20-007144
10-Q2020-05-06fiscal Q1 202041850001387131-20-004479
10-K2020-02-24fiscal FY 2019431340001387131-20-002086
10-Q2019-11-08fiscal Q3 2019411180001387131-19-008469
10-Q2019-08-09fiscal Q2 2019391060001387131-19-005935
10-Q2019-05-08fiscal Q1 201939750001387131-19-003457
10-K2019-02-27fiscal FY 2018371200001387131-19-001471
10-Q2018-11-08fiscal Q3 201836930001387131-18-005976
10-Q2018-07-30fiscal Q2 201833860001387131-18-003401
10-Q2018-05-07fiscal Q1 201832640001387131-18-001945
10-K2018-02-23fiscal FY 2017331030001387131-18-000776
10-Q2017-11-07fiscal Q3 201733860001387131-17-005313
10-Q2017-08-03fiscal Q2 201733850001387131-17-003894
10-Q2017-05-03fiscal Q1 201733650001387131-17-002419
10-K2017-02-28fiscal FY 2016331030001387131-17-001111
10-Q2016-11-04fiscal Q3 201634880001387131-16-007716
10-Q2016-08-05fiscal Q2 201634880001387131-16-006337
10-Q2016-05-05fiscal Q1 201632630001387131-16-005278
10-K2016-02-26fiscal FY 2015331040001387131-16-004361
10-Q2015-11-05fiscal Q3 201534880001387131-15-003188
10-Q2015-08-07fiscal Q2 201534870001387131-15-002352
10-Q2015-05-07fiscal Q1 201534660001387131-15-001534
10-K2015-03-12fiscal FY 2014341150001387131-15-000875
10-Q2014-11-07fiscal Q3 201433890001387131-14-003647
10-Q2014-08-07fiscal Q2 201433850001387131-14-002744
10-Q2014-05-07fiscal Q1 201434660001387131-14-001673
10-K2014-03-05fiscal FY 2013361130001387131-14-000771
10-Q2013-11-05fiscal Q3 201333830001387131-13-004064
10-Q2013-08-07fiscal Q2 201333830001387131-13-002760
10-Q2013-05-10fiscal Q1 201333670001387131-13-001675
10-K2013-03-12fiscal FY 201234730001387131-13-000737
10-Q2012-11-13fiscal Q3 201233850001387131-12-003625
10-Q2012-08-09fiscal Q2 201232840001387131-12-002558
10-Q2012-05-11fiscal Q1 201232650001387131-12-001510
10-K2012-03-27fiscal FY 201133370001387131-12-000862
10-Q2011-11-07fiscal Q3 201126610001387131-11-002429
10-Q2011-08-15fiscal Q2 201121500001387131-11-001704

Inspect the source

Entity
TherapeuticsMD, Inc. / CIK 0000025743
Captured
2026-09-19T14:45:35.881Z
SEC response SHA-256
566f636dfc852372b704143e2678a66d8d716f0795f8652994459dcc9f22859d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000025743.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))